Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add filters

Language
Document Type
Year range
1.
NeuroQuantology ; 20(12):1938-1953, 2022.
Article in English | EMBASE | ID: covidwho-2091011

ABSTRACT

More than a decade has passed since internationally recognized universities and colleges began using online teaching and learning methods to fulfill the needs of students who reside a long distance away from their places of higher education. Internet teaching and learning proved to be a lifesaver for many educational institutions and students during the COVID-19 outbreak in 2014. Students from universities and colleges around the country are participating in a poll to determine the success of online teaching and learning. An online survey will be conducted, and the findings will be made available to the community. It was decided to do this by developing a questionnaire circulated among college and university students. Approximately 500 students from various universities, engineering schools, and medical institutions participated in and submitted the survey results. In a study, it was discovered that the use of animation, digital collaboration with peers, video lectures by subject-matter experts, multiple-choice questions in online quizzes, student version software, a conducive learning environment at home, interactions by professors during lessons, and online materials provided by faculty could all help to improve online learning. Since they may all view PowerPoint presentations in front of them at any volume level, they wish while in an internet-based classroom, students no longer have to walk or drive to class when in an internet-based classroom. Copyright © 2022, Anka Publishers. All rights reserved.

2.
Pakistan Journal of Botany ; 54(4):1-11, 2022.
Article in English | Scopus | ID: covidwho-1737558

ABSTRACT

In present scenario, World needs prevention and control of SARS-COV2 ailment epidemic. To manage overall sheer carrier and sufferers of covid-19 needs intensive medical assistance and adjunctive treatment plans to overcome the malady. The outbreak can be coped with support of ailment suppression through public fitness measures and adjunctive treatments for patients. In Pakistan due to scarce health care amenities, most of the rural population rely upon indigenous traditional medicinal plant (TMPs) resources. Due to lack of proper anti-covid-19 therapy, TMPs/ herbal treatments could be helpful as first line of defence. It is indispensable to securitize potent repurposed TMPS to impede viral entry, viral proliferation manifestations, inflammation and immunity booster as major weapons against the COVID-19. However, most of these TMPs are being examined in a lot of molecular docking analysis, In vitro In vivo experimentation and in clinical trials at various levels. Auxiliary to this, review describes current hallmark of vitamins research in efficient functioning of immune system. This overview suggested that traditional medicinal plants are safe and have enough hierarchy of evidence to use them as adjunctive treatment. This review compiles, the medicinal plants with potent bioactive compounds to devise fast and sensitive adjunctive therapy and for further planning to explore suitable candidates for drug development. © 2022, Pakistan Botanical Society. All rights reserved.

3.
Pakistan Journal of Pharmaceutical Sciences ; 34(4):1467-1484, 2021.
Article in English | Scopus | ID: covidwho-1527161

ABSTRACT

Currently, prevention and control of the coronavirus disease pneumonia epidemic situation are grim globally. To cope with total sheer carriers and patients of COVID-19 requires intensive medical support and adjunctive therapies to overcome the disease. The epidemic can be controlled with the help of both, disease suppression via community health measures and adjunctive therapies for patients suffering from infection. Till date, we do not have any proper antiCOVID-19 therapy. In order to achieve the overall realization of this pandemic, there is a need to identify treatments depending upon their direct or indirect targets;like inhibition of polyprotein synthesis, transmembrane serine protease, inhibition of viral entry and endocytosis. This could be possible by turning the focus in the direction towards the development of numerous tentative drugs, particularly in the severe to badly ill. Though, majority of these off-label adjunctive medicines are being inspected in a lot of clinical trials at different stages, scientific organizations have endeavored to elucidate the situation where these adjunctive drugs might be practiced as off-label, open- label or compassionate. Our review compiles the adjunctive therapies adopted in COVID-19 infected patients according to clinical severity in conjugation with practicing recommendations from existing guidance rules issued by global professional bodies in healthcare. © 2021 Pakistan Journal of Pharmaceutical Sciences. All rights reserved.

4.
Pak J Pharm Sci ; 34(4):1469-1484, 2021.
Article in English | PubMed | ID: covidwho-1525057

ABSTRACT

Currently, prevention and control of the coronavirus disease pneumonia epidemic situation are grim globally. To cope with total sheer carriers and patients of COVID-19 requires intensive medical support and adjunctive therapies to overcome the disease. The epidemic can be controlled with the help of both, disease suppression via community health measures and adjunctive therapies for patients suffering from infection. Till date, we do not have any proper anti-COVID-19 therapy. In order to achieve the overall realization of this pandemic, there is a need to identify treatments depending upon their direct or indirect targets;like inhibition of polyprotein synthesis, transmembrane serine protease, inhibition of viral entry and endocytosis. This could be possible by turning the focus in the direction towards the development of numerous tentative drugs, particularly in the severe to badly ill. Though, majority of these off-label adjunctive medicines are being inspected in a lot of clinical trials at different stages, scientific organizations have endeavored to elucidate the situation where these adjunctive drugs might be practiced as off-label, open- label or compassionate. Our review compiles the adjunctive therapies adopted in COVID-19 infected patients according to clinical severity in conjugation with practicing recommendations from existing guidance rules issued by global professional bodies in healthcare.

SELECTION OF CITATIONS
SEARCH DETAIL